Decipher Labs Ltd

DECIPHER

Watchlist

AI Mode

‌

Market Cap

₹ 10 Cr

P/E

—

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

UNDER PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

LOW MARGIN

Technicals

Bearish

Risk

LOW RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Decipher Labs Ltd., formerly known as Combat Drugs Ltd, is a diversified public company engaged in manufacturing and marketing pharmaceuticals and providing IT solutions.

The company has expanded its operations with the acquisition of Decipher Software Solutions LLC in the USA, indicating a strategic focus on IT solutions.

Decipher Labs has a reputable presence in the pharmaceutical sector, manufacturing and marketing branded formulations, bulk drugs, and chemical supplies accepted by the trade and medical community.

The company operates a full-fledged manufacturing unit in Hyderabad, producing various pharmaceutical formulations including tablets, capsules, and liquids.

Decipher Labs is actively exploring export opportunities to Nigeria and the West Indies, signaling a potential increase in international market exposure.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

10 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

0.5

52W High

17.25

52W Low

9.00

Sales CAGR

-36.98%

-4.78%

-9.73%

10Y

16.08%

Profit CAGR

-202.38%

—

10Y

—

ROE

TTM

-42.34%

-11.53%

-5.26%

10Y

-4.82%

ROCE

TTM

-50.18%

-11.60%

-5.26%

10Y

-4.81%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
CHCL	5.30	13 Cr	—	0.41	0.00	-15.06	2.17	-12.46
BERLDRG	21.90	11 Cr	47.41	1.17	0.00	2.47	7.06	1.32
ORTINGLOBE	13.25	11 Cr	—	8.31	0.00	-73.01	-42.20	-24.80
DECIPHER	9.75	10 Cr	—	0.51	0.00	-42.34	-50.18	-34.13
VIVANZA	2.04	8 Cr	—	1.77	0.00	-6.62	-0.04	-0.62
HINDBIO	6.09	6 Cr	304.50	7.26	0.00	2.56	0.67	0.57
BRAWN	20.00	6 Cr	30.65	1.90	0.00	—	—	0.00

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	9.51	7.49	8.29	11	7.44	5.87	5.80	3.50	2.92	4.31
Expenses	9.65	9.66	8.15	9.38	6.13	7.20	6.44	10	6.24	4.19
Operating Profit	-0.14	-2.17	0.14	1.21	1.31	-1.33	-0.64	-6.57	-3.32	0.12
OPM %	-1.47	-28.97	1.69	11.43	17.61	-22.66	-11.03	-187.71	-113.70	2.78
Other Income	0.01	0.14	0.00	0.27	0.16	0.12	0.17	0.87	0.01	0.02
Interest	0.01	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.11	0.11	0.12	0.11	0.11	0.12	0.12	0.13	0.12	0.13
Profit Before Tax	-0.25	-2.14	0.01	1.16	1.36	-1.33	-0.58	-5.83	-3.42	0.02
Tax %	-280.00	9.35	0.00	-3.45	30.15	0.00	-1.72	29.67	0.00	0.00
Net Profit	-0.95	-1.94	0.01	1.20	0.95	-1.33	-0.59	-4.11	-3.43	0.02
EPS in Rs	-0.94	-1.92	0.01	1.19	0.94	-1.31	-0.59	-4.07	-3.39	0.02

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	1.02	8.06	24	56	65	46	36	23	18
Expenses	0.95	7.62	22	52	59	54	37	30	30
Operating Profit	0.07	0.44	2.47	3.45	6.03	-8.43	-0.96	-7.23	-12
OPM %	6.76	5.48	10.30	6.21	9.22	-18.51	-2.67	-31.97	-65.56
Other Income	0.11	0.00	0.27	0.65	7.67	5.13	0.42	1.32	1.17
Interest	0.00	0.00	0.72	1.13	0.48	0.43	0.22	0.00	0.00
Depreciation	0.00	0.00	0.56	0.82	0.87	0.43	0.45	0.48	0.49
Profit Before Tax	0.18	0.44	1.47	2.14	12	-4.16	-1.21	-6.39	-11
Tax %	0.00	8.03	24.91	34.55	7.87	35.51	-38.35	20.45	15.23
Net Profit	0.18	0.41	1.10	1.40	11	-2.68	-1.68	-5.08	-9.46
EPS in Rs	—	0.40	1.09	1.41	11.28	-4.88	-1.66	-5.03	-8.03
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	8.00	8.00	10	10	10	10	10	10
Reserves	-5.88	-5.47	2.46	3.59	14	13	12	13
Borrowings	0.13	0.20	11	10	10	0.95	0.00	0.24
Other Liabilities	0.71	3.61	12	15	7.46	4.01	12	2.66
Total Liabilities	2.96	6.34	35	39	42	28	34	26
Fixed Assets	0.00	0.01	4.98	4.43	2.83	3.31	2.91	2.54
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.26	3.76	5.49	0.26
Other Assets	2.96	6.34	30	34	39	21	25	23
Total Assets	2.96	6.34	35	39	42	28	34	26

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.10	0.23	-15	1.83	8.26	-1.56	4.85	-9.82
Cash from Investing Activity	0.00	-0.02	-0.01	-0.31	-1.13	-4.28	-1.79	3.07
Cash from Financing Activity	0.09	0.07	16	3.99	1.30	-2.15	-1.17	0.24
Net Cash Flow	-0.01	0.28	1.17	5.51	8.43	-7.99	1.90	-6.51

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	16.43%	16.43%	16.43%	16.43%	16.43%	16.43%	16.43%	16.43%	16.43%	16.43%	16.43%	16.43%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	83.57%	83.57%	83.57%	83.57%	83.57%	83.57%	83.57%	83.57%	83.57%	83.57%	83.57%	83.57%
Total Shareholders	40,027	38,292	37,166	35,728	34,511	33,371	32,833	31,838	31,482	31,182	30,512	30,174

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Jun 12, 2024	Mehulkumar natubhai panucha	Bulk	Sell	23.26	0.25 Cr	1,06,382	1.05
Jun 12, 2024	Krunalkumar kanuji thakor	Bulk	Buy	23.88	0.02 Cr	7,634	0.07
Jun 12, 2024	Krunalkumar kanuji thakor	Bulk	Sell	24.00	0.18 Cr	73,134	0.72
Jun 12, 2024	Mehulkumar natubhai panucha	Bulk	Buy	24.12	0.35 Cr	1,44,337	1.42
Jun 11, 2024	Krunalkumar kanuji thakor	Bulk	Buy	19.20	0.13 Cr	66,032	0.65
Jun 11, 2024	Krunalkumar kanuji thakor	Bulk	Sell	18.00	0.00 Cr	532	0.00
May 15, 2024	Rajesh manubhai shah	Bulk	Sell	14.94	0.11 Cr	71,000	0.70
Apr 11, 2023	Suriadoss elumalai .	Bulk	Buy	23.48	0.16 Cr	69,953	0.69

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
CHCL	5.30	13 Cr	—	0.41	0.00	-15.06	2.17	-12.46
BERLDRG	21.90	11 Cr	47.41	1.17	0.00	2.47	7.06	1.32
ORTINGLOBE	13.25	11 Cr	—	8.31	0.00	-73.01	-42.20	-24.80
DECIPHER	9.75	10 Cr	—	0.51	0.00	-42.34	-50.18	-34.13
VIVANZA	2.04	8 Cr	—	1.77	0.00	-6.62	-0.04	-0.62
HINDBIO	6.09	6 Cr	304.50	7.26	0.00	2.56	0.67	0.57
BRAWN	20.00	6 Cr	30.65	1.90	0.00	—	—	0.00

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	9.51	7.49	8.29	11	7.44	5.87	5.80	3.50	2.92	4.31
Expenses	9.65	9.66	8.15	9.38	6.13	7.20	6.44	10	6.24	4.19
Operating Profit	-0.14	-2.17	0.14	1.21	1.31	-1.33	-0.64	-6.57	-3.32	0.12
OPM %	-1.47	-28.97	1.69	11.43	17.61	-22.66	-11.03	-187.71	-113.70	2.78
Other Income	0.01	0.14	0.00	0.27	0.16	0.12	0.17	0.87	0.01	0.02
Interest	0.01	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.11	0.11	0.12	0.11	0.11	0.12	0.12	0.13	0.12	0.13
Profit Before Tax	-0.25	-2.14	0.01	1.16	1.36	-1.33	-0.58	-5.83	-3.42	0.02
Tax %	-280.00	9.35	0.00	-3.45	30.15	0.00	-1.72	29.67	0.00	0.00
Net Profit	-0.95	-1.94	0.01	1.20	0.95	-1.33	-0.59	-4.11	-3.43	0.02
EPS in Rs	-0.94	-1.92	0.01	1.19	0.94	-1.31	-0.59	-4.07	-3.39	0.02

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	1.02	8.06	24	56	65	46	36	23	18
Expenses	0.95	7.62	22	52	59	54	37	30	30
Operating Profit	0.07	0.44	2.47	3.45	6.03	-8.43	-0.96	-7.23	-12
OPM %	6.76	5.48	10.30	6.21	9.22	-18.51	-2.67	-31.97	-65.56
Other Income	0.11	0.00	0.27	0.65	7.67	5.13	0.42	1.32	1.17
Interest	0.00	0.00	0.72	1.13	0.48	0.43	0.22	0.00	0.00
Depreciation	0.00	0.00	0.56	0.82	0.87	0.43	0.45	0.48	0.49
Profit Before Tax	0.18	0.44	1.47	2.14	12	-4.16	-1.21	-6.39	-11
Tax %	0.00	8.03	24.91	34.55	7.87	35.51	-38.35	20.45	15.23
Net Profit	0.18	0.41	1.10	1.40	11	-2.68	-1.68	-5.08	-9.46
EPS in Rs	—	0.40	1.09	1.41	11.28	-4.88	-1.66	-5.03	-8.03
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	8.00	8.00	10	10	10	10	10	10
Reserves	-5.88	-5.47	2.46	3.59	14	13	12	13
Borrowings	0.13	0.20	11	10	10	0.95	0.00	0.24
Other Liabilities	0.71	3.61	12	15	7.46	4.01	12	2.66
Total Liabilities	2.96	6.34	35	39	42	28	34	26
Fixed Assets	0.00	0.01	4.98	4.43	2.83	3.31	2.91	2.54
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.26	3.76	5.49	0.26
Other Assets	2.96	6.34	30	34	39	21	25	23
Total Assets	2.96	6.34	35	39	42	28	34	26

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.10	0.23	-15	1.83	8.26	-1.56	4.85	-9.82
Cash from Investing Activity	0.00	-0.02	-0.01	-0.31	-1.13	-4.28	-1.79	3.07
Cash from Financing Activity	0.09	0.07	16	3.99	1.30	-2.15	-1.17	0.24
Net Cash Flow	-0.01	0.28	1.17	5.51	8.43	-7.99	1.90	-6.51

Overview

Detailed Summary

Decipher Labs Ltd., formerly known as Combat Drugs Ltd, is a diversified public company engaged in manufacturing and marketing pharmaceuticals and providing IT solutions.

The company has expanded its operations with the acquisition of Decipher Software Solutions LLC in the USA, indicating a strategic focus on IT solutions.

Decipher Labs has a reputable presence in the pharmaceutical sector, manufacturing and marketing branded formulations, bulk drugs, and chemical supplies accepted by the trade and medical community.

The company operates a full-fledged manufacturing unit in Hyderabad, producing various pharmaceutical formulations including tablets, capsules, and liquids.

Decipher Labs is actively exploring export opportunities to Nigeria and the West Indies, signaling a potential increase in international market exposure.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

10 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

0.5

52W High

17.25

52W Low

9.00

Sales CAGR

-36.98%

-4.78%

-9.73%

10Y

16.08%

Profit CAGR

-202.38%

—

10Y

—

ROE

TTM

-42.34%

-11.53%

-5.26%

10Y

-4.82%

ROCE

TTM

-50.18%

-11.60%

-5.26%

10Y

-4.81%